Multiple prostatic calculi: a case series and literature review
Abstract
The reported prevalence of prostatic calculi / stones ranges from 7% to 99% and depends on patient age. Prostatic calculi are found in 9% of men aged 18 – 29 years, in 32.3% of those aged 50 – 59 years, and in 66.7% of those aged 70 – 79 years. Prostatic calculi associated with benign prostatic hyperplasia (BPH) are often asymptomatic and are usually detected incidentally during surgical treatment of BPH. Large or multiple calculi, as well as stones associated with chronic prostatic inflammation, may cause nonspecific lower urinary tract symptoms (LUTS). In addition, patients with prostatic calculi may present with hematuria, post‑micturition dribbling, urinary incontinence, and chronic pelvic pain syndrome. Prostatic calculi occurring in the setting of chronic inflammation of the gland can serve as a nidus for bacterial colonization and may promote the selection of microorganisms resistant to antimicrobial therapy. Asymptomatic calculi generally do not require specific treatment and are most often removed incidentally during surgery for prostate cancer. In symptomatic cases, the efficacy of conservative treatment, particularly antibiotic therapy, is limited because the stones themselves represent a persistent source of infection. Therefore, in such patients, the preferred management option, in combination with antibacterial therapy, is endoscopic removal. In this paper, we present our clinical cases in patients with multiple symptomatic and asymptomatic prostatic calculi…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.